<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01734135</url>
  </required_header>
  <id_info>
    <org_study_id>CHFQUERI-1101</org_study_id>
    <nct_id>NCT01734135</nct_id>
  </id_info>
  <brief_title>Provider Notification for High B-type Natriuretic Peptide Values</brief_title>
  <official_title>Trial of Provider Notification for Patients With High B-type Natriuretic Peptide and no Imaging to Identify Unsuspected Heart Failure.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Palo Alto Health Care System</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Palo Alto Health Care System</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This proposal examines use of a clinical reminder to the primary provider of patient with a
      high B type natriuretic peptide but no prior imaging.

      Electrical Medical Record-based Intervention to Determine whether Clinical Reminders Improve
      Heart Failure Management in Patients with High BNP Values and Unknown LVEF.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Rationale: B type natriuretic peptide is known to be elevated (&gt; 100 pg/ml) in patients with
      heart failure. Furthermore, treatments are available to improve survival and reduce
      hospitalization if the left ventricular ejection fraction (LVEF) is &lt; 40%. Accordingly,
      guidelines recommend an LVEF measure for patients with suspected heart failure. Prior work
      has demonstrated that patients with high BNP values do not always have a measure of left
      ventricular ejection.

      Hypothesis: A reminder to patients with BNP and no imaging may prompt providers to order
      appropriate imaging potentially leading to 1) identification of unsuspected depressed
      ejection fraction and 2) more appropriate treatment.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2010</start_date>
  <completion_date type="Actual">September 2015</completion_date>
  <primary_completion_date type="Actual">September 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Measurement of left ventricular ejection fraction</measure>
    <time_frame>6 months after randomization</time_frame>
    <description>numerator: Measurement of left ventricular ejection fraction within 6 months of randomization.
denominator: All randomized patients</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Identification of LVEF &lt; 40%</measure>
    <time_frame>6 months following randomizaiton</time_frame>
    <description>Numerator: number of patients identified with an LVEF&lt; 40% Denominator: all randomized patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment of Low LVEF</measure>
    <time_frame>6 months following randomization</time_frame>
    <description>Numerator: number of patients with an LVEF &lt; 40% and treatment with either an angiotensin converting enzyme inhibitor, angiotensin receptor blocker or evidence based beta-blocker (carvedilol, metoprolol succinate, bisoprolol).
Denominator: all randomized patients.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">115</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Usual Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Usual care</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Clinical Reminder</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A note is sent to the primary care provider using the electronic medical record indicating the high BNP result and potential benefit of measurement of the left ventricular ejection fraction. A draft order is placed for an echocardiogram for the provider to accept or delete.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Clinical Reminder</intervention_name>
    <description>A note is sent to the primary care provider using the electronic medical record indicating the high BNP result and potential benefit of measurement of the left ventricular ejection fraction. A draft order is placed for an echocardiogram for the provider to accept or delete.</description>
    <arm_group_label>Clinical Reminder</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BNP &gt;= 200 pg/ml in last 2 months

        Exclusion Criteria:

          -  Measure of LVEF in the last 12 months

          -  Last measure of LVEF &lt; 40%
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paul A Heidenreich, MD, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA Palo Alto HCS</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>VA Palo Alto Health Care System</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 20, 2012</study_first_submitted>
  <study_first_submitted_qc>November 20, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 27, 2012</study_first_posted>
  <last_update_submitted>April 26, 2016</last_update_submitted>
  <last_update_submitted_qc>April 26, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 28, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>VA Palo Alto Health Care System</investigator_affiliation>
    <investigator_full_name>Paul Heidenreich</investigator_full_name>
    <investigator_title>Investigator</investigator_title>
  </responsible_party>
  <keyword>B type natriuretic peptide</keyword>
  <keyword>heart failure</keyword>
  <keyword>cardiac imaging</keyword>
  <keyword>quality of care</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Natriuretic Peptide, Brain</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

